Abstract
The quest for the discovery of new antihyperglycaemic agents has been more intense the last years due to the rapid increase of mortality associated with type 2 diabetes. Glycogen metabolism has been one of the major causes of the elevated blood glucose levels; hence, special attention has been drawn to the control of the enzymes implicated in the relevant pathway. To this end, the allosteric enzyme of glycogen phosphorylase, has been proposed as molecular target for the design of potential new antidiabetic agents by an interdisciplinary approach comprising organic synthesis, kinetic and Xray crystallographic studies and physiological experiments. The results derived from the thorough investigation of the catalytic site of the enzyme with the structure-based inhibitor design approach are summarized with emphasis on the most potent inhibitors identified for different classes of compounds.
Keywords: Glycogen phosphorylase, structure-based drug design, type 2 diabetes, X-ray crystallography, β-D-glucopyranosyl analogues, antihyperglycaemic agents, blood glucose levels, D-glucopyranosyl analogues., insulin resistance pathways, glycated hemoglobin, metformin, sulfonylureas, glinides, glucosidase inhibitors, thiazolinidinediones, insulin, gluca-gon-like peptide-1 agonists, amylin agonists, dipeptidyl peptidase-4 inhibitors, hyperglycemia, hypoglycemia, glycogen metabolism, glycogenolysis, glu-coneogenesis, glycogen phosphory-lase, glu-cose-1-phosphate (Glc-1-P), glucose homeostasis, allosteric inhibitors, allosteric activators, Ser14-phosphate recognition site, benzimidazole site, pyridoxal 5, ’, -phosphate, pocket, ANTIDIABETICS, glucopyranose amides, D-glucoseN-Acetyl--D-glucopyranosylamine, D-glucose,, naphthyl group, RMGPb, glucopyranosylidene ana-logues, D-glucopyranosylidene-spiro-oxathiazole, NMR, mass spectrometry
Mini-Reviews in Medicinal Chemistry
Title: The Prototype of Glycogen Phosphorylase
Volume: 10 Issue: 12
Author(s): E. D.Chrysina
Affiliation:
Keywords: Glycogen phosphorylase, structure-based drug design, type 2 diabetes, X-ray crystallography, β-D-glucopyranosyl analogues, antihyperglycaemic agents, blood glucose levels, D-glucopyranosyl analogues., insulin resistance pathways, glycated hemoglobin, metformin, sulfonylureas, glinides, glucosidase inhibitors, thiazolinidinediones, insulin, gluca-gon-like peptide-1 agonists, amylin agonists, dipeptidyl peptidase-4 inhibitors, hyperglycemia, hypoglycemia, glycogen metabolism, glycogenolysis, glu-coneogenesis, glycogen phosphory-lase, glu-cose-1-phosphate (Glc-1-P), glucose homeostasis, allosteric inhibitors, allosteric activators, Ser14-phosphate recognition site, benzimidazole site, pyridoxal 5, ’, -phosphate, pocket, ANTIDIABETICS, glucopyranose amides, D-glucoseN-Acetyl--D-glucopyranosylamine, D-glucose,, naphthyl group, RMGPb, glucopyranosylidene ana-logues, D-glucopyranosylidene-spiro-oxathiazole, NMR, mass spectrometry
Abstract: The quest for the discovery of new antihyperglycaemic agents has been more intense the last years due to the rapid increase of mortality associated with type 2 diabetes. Glycogen metabolism has been one of the major causes of the elevated blood glucose levels; hence, special attention has been drawn to the control of the enzymes implicated in the relevant pathway. To this end, the allosteric enzyme of glycogen phosphorylase, has been proposed as molecular target for the design of potential new antidiabetic agents by an interdisciplinary approach comprising organic synthesis, kinetic and Xray crystallographic studies and physiological experiments. The results derived from the thorough investigation of the catalytic site of the enzyme with the structure-based inhibitor design approach are summarized with emphasis on the most potent inhibitors identified for different classes of compounds.
Export Options
About this article
Cite this article as:
D.Chrysina E., The Prototype of Glycogen Phosphorylase, Mini-Reviews in Medicinal Chemistry 2010; 10 (12) . https://dx.doi.org/10.2174/1389557511009011093
DOI https://dx.doi.org/10.2174/1389557511009011093 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Different Pharmacokinetic Responses to an Acute Dose of Inorganic Nitrate in Patients with Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Short and Long Term Effects of a DPP-4 Inhibitor Versus Bedtime NPH Insulin as ADD-ON Therapy in Patients with Type 2 Diabetes
Current Pharmaceutical Design Editorial [Hot Topic: Promote Healthy Eating in Women of Childbearing Age (Guest Editor: Hiroko Watanabe)]
Current Nutrition & Food Science A Comprehensive Review on Recent advances in Synthesis & Pharmacotherapeutic potential of Benzothiazoles
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry A Systematic Review of Randomized Controlled Trials Examining the Nephroprotective Properties of Antihypertensive Medications
Current Hypertension Reviews Interactions of Biologically Active Factors and Vascular Mediators During Hypertension in Pregnancy
Current Hypertension Reviews Renin-Angiotensin Antagonists: Therapeutic Effects Beyond Blood Pressure Control?
Current Pharmaceutical Design Risk of Vertical HIV Transmission Combines the ‘B35-Cw4 Disadvantage’ and the ‘Pattern of Inheritance’ Theories of Progression
Current HIV Research Refining Genetic Approaches for Identifying Behavioral Loci
Current Genomics An Update on Autoinflammatory Diseases
Current Medicinal Chemistry Biochemical, Biomedical and Metabolic Aspects of Imidazole-Containing Dipeptides with the Inherent Complexity to Neurodegenerative Diseases and Various States of Mental Well-Being: A Challenging Correction and Neurotherapeutic Pharmaceutical Biotechnology for Treating Cognitive Deficits, Depression and Intellectual Disabilities
Current Pharmaceutical Biotechnology Early Cerebral Infarction Following Aneurysmal Subarachnoid Hemorrhage: Frequency, Risk Factors, Patterns, and Prognosis
Current Neurovascular Research Does Global Gene Expression Analysis in Type 2 Diabetes Provide an Opportunity to Identify Highly Promising Drug Targets?
Endocrine, Metabolic & Immune Disorders - Drug Targets Diabetic Peripheral Neuropathy: Diagnosis and Treatment
Current Drug Safety Poor Response to Antiplatelet Drugs. An Important Issue in Drug-Eluting Stents.
Current Clinical Pharmacology Chemoprevention with Phytonutrients and Microalgae Products in Chronic Inflammation and Colon Cancer
Current Pharmaceutical Design Indoor Dust Levels of Perfluoroalkyl Substances (PFASs) and the Role of Ingestion as an Exposure Pathway: A Review
Current Organic Chemistry Anti-Inflammatory Properties of Drugs from saffron crocus
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Immunomodulatory Effects of Medicinal Plants used for Vitiligo in Traditional Persian Medicine
Current Drug Discovery Technologies An Animal Model to Study Digesta Passage in Different Compartments of the Gastro-Intestinal Tract (GIT) as Affected by Dietary Composition
Current Nutrition & Food Science